Page last updated: 2024-11-07

propidium iodide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Propidium iodide is a fluorescent dye that is commonly used in flow cytometry, microscopy, and molecular biology. It is a cationic dye that binds to nucleic acids, with a strong preference for double-stranded DNA. The dye is impermeable to intact cell membranes, but can enter cells that have damaged membranes, allowing for the differentiation of live and dead cells. Propidium iodide is often used in conjunction with other dyes, such as fluorescein diacetate, to distinguish between viable, apoptotic, and necrotic cells. Its use in molecular biology involves DNA staining to quantify DNA content in cells, as well as in gel electrophoresis to visualize DNA fragments. Propidium iodide has also been used in research to study the mechanisms of DNA damage and repair, as well as to develop new cancer therapies. '

Cross-References

ID SourceID
PubMed CID104981
CHEMBL ID345124
CHEBI ID51240
SCHEMBL ID14996
MeSH IDM0017756

Synonyms (52)

Synonym
LS-15196
CHEBI:51240 ,
3,8-diamino-5-{3-[diethyl(methyl)ammonio]propyl}-6-phenylphenanthridinium diiodide
phenanthridinium, 3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenyl-, diiodide
propidium diiodide
3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenylphenanthridinium diiodide
3,8-diamino-5-(3-diethylaminopropyl)-6-phenylphenanthridinium iodide methiodide
einecs 247-081-0
nsc 169541
25535-16-4
propidium iodide
PRESTWICK_1017
nsc-169541
chembl345124 ,
propidium iodine
2,7-diamino-9-phenyl-10 (diethylaminopropyl)-phenanthridium iodide methiodide
HMS1570O06
3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium diiodide
sr-01000841195
HMS2097O06
FT-0674066
tp416o228t ,
unii-tp416o228t
AKOS015904636
3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide
CCG-220792
SCHEMBL14996
phenanthridinium, 3,8-diamino-5-(3-(diethylmethylammonio)propyl)-6-phenyl-, iodide (1:2)
propidiumiodide
c27h34i2n4
3,8-diamino-5-(3-(diethyl(methyl)ammonio)propyl)-6-phenylphenanthridin-5-ium iodide
CS-7538
HB0820
HMS3403D19
mfcd00011921
SR-01000841195-2
HMS3714O06
HY-D0815
propidium (iodide)
3,8-diamino-5-(3-(diethyl(methyl)ammonio)propyl)-6-phenylphenanthridinium iodide
XJMOSONTPMZWPB-UHFFFAOYSA-M
DTXSID20894084
propidium iodide - cas 25535-16-4
bdbm50235326
BCP29152
propidium iodine and 3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diiodide
3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium;diiodide
3-(3,8-diamino-6-phenylphenanthridin-5-ium-5-yl)propyl-diethyl-methylazanium;iodide
2,7-diamino-9-phenyl-10 (diethylaminopropyl)-phenanthridium iodide methiodide aqueous solution
HB0821
propidium iodide staining solution (1mg/ml) in water
3,8-diamino-5-(3-(diethyl(methyl)ammonio)propyl)-6-phenylphenanthridin-5-iumiodide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic iodide salt
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (8)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseElectrophorus electricus (electric eel)Ki8.10000.00121.25638.9000AID366355; AID499449
AcetylcholinesteraseTetronarce californica (Pacific electric ray)Ki3.73000.00000.76714.3000AID404434
CholinesteraseHomo sapiens (human)IC50 (µMol)13.20000.00001.559910.0000AID1071355; AID241298; AID298279; AID345206; AID427189; AID595290
AcetylcholinesteraseMus musculus (house mouse)IC50 (µMol)1.10000.00071.11818.4000AID1054123
AcetylcholinesteraseMus musculus (house mouse)Ki2.23000.00001.42829.3000AID404437
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)26.81080.00000.933210.0000AID1071357; AID1437480; AID241279; AID282830; AID298278; AID314091; AID314112; AID318851; AID345205; AID427188; AID482894; AID595289; AID697833
AcetylcholinesteraseHomo sapiens (human)Ki7.14000.00001.27869.7300AID238797
Acetylcholinesterase Bos taurus (cattle)IC50 (µMol)20.44450.00000.61068.7000AID404439; AID427187
Reverse transcriptase/RNaseH Human immunodeficiency virus 1IC50 (µMol)3.00000.00011.076810.0000AID695925
Carboxylic ester hydrolase Equus caballus (horse)IC50 (µMol)12.60000.00512.69848.5000AID247996
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AcetylcholinesteraseMus musculus (house mouse)Kd1.10000.01800.55901.1000AID31795
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (25)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processCholinesteraseHomo sapiens (human)
learningCholinesteraseHomo sapiens (human)
negative regulation of cell population proliferationCholinesteraseHomo sapiens (human)
neuroblast differentiationCholinesteraseHomo sapiens (human)
peptide hormone processingCholinesteraseHomo sapiens (human)
response to alkaloidCholinesteraseHomo sapiens (human)
cocaine metabolic processCholinesteraseHomo sapiens (human)
negative regulation of synaptic transmissionCholinesteraseHomo sapiens (human)
response to glucocorticoidCholinesteraseHomo sapiens (human)
response to folic acidCholinesteraseHomo sapiens (human)
choline metabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
amyloid-beta bindingCholinesteraseHomo sapiens (human)
catalytic activityCholinesteraseHomo sapiens (human)
acetylcholinesterase activityCholinesteraseHomo sapiens (human)
cholinesterase activityCholinesteraseHomo sapiens (human)
protein bindingCholinesteraseHomo sapiens (human)
hydrolase activity, acting on ester bondsCholinesteraseHomo sapiens (human)
enzyme bindingCholinesteraseHomo sapiens (human)
choline bindingCholinesteraseHomo sapiens (human)
identical protein bindingCholinesteraseHomo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
amyloid-beta bindingAcetylcholinesterase Bos taurus (cattle)
protein bindingAcetylcholinesterase Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
extracellular regionCholinesteraseHomo sapiens (human)
nuclear envelope lumenCholinesteraseHomo sapiens (human)
endoplasmic reticulum lumenCholinesteraseHomo sapiens (human)
blood microparticleCholinesteraseHomo sapiens (human)
plasma membraneCholinesteraseHomo sapiens (human)
extracellular spaceCholinesteraseHomo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesterase Bos taurus (cattle)
side of membraneAcetylcholinesterase Bos taurus (cattle)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (82)

Assay IDTitleYearJournalArticle
AID595292Inhibition of human AChE-induced beta-amyloid (1-40) aggregation at 100 uM by thioflavin-T based fluorimetric assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID241298Inhibition of Butyrylcholinesterase2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
AID744310Antioxidant activity of the compound assessed as trolox equivalent of APPH-induced radical scavenging activity at 5 uM incubated for 15 mins measured every 1 min for 240 mins by ORAC-FL assay2013European journal of medicinal chemistry, May, Volume: 63Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID1437480Inhibition of human AchE-induced amyloid beta (1 to 40) aggregation after 48 hrs by thioflavin T fluorescence spectroscopic method2017European journal of medicinal chemistry, Mar-10, Volume: 128A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease.
AID404434Inhibition of Torpedo californica AChE2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
AID318851Inhibition of human recombinant AChE-induced amyloid beta aggregation by thioflavin T fluorescence method2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
AID427187Inhibition of bovine AChE by Ellman's method2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
AID648659Inhibition of equine serum BChE after 15 mins incubation by spectrophotometry based Ellman's method2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID592643Inhibition of human AChE-induced amyloid beta (1-40) aggregation at 100 uM after 24 hrs by thioflavin T based fluorometric assay2011Bioorganic & medicinal chemistry, Apr-01, Volume: 19, Issue:7
Design, synthesis and structure-activity relationship (SAR) studies of 2,4-disubstituted pyrimidine derivatives: dual activity as cholinesterase and Aβ-aggregation inhibitors.
AID600117Inhibition of human recombinant AChE-induced amyloid beta (1-40) aggregation assessed as fibril formation at 100 uM by thioflavin T-based fluorometric assay2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
New potent human acetylcholinesterase inhibitors in the tetracyclic triterpene series with inhibitory potency on amyloid β aggregation.
AID697850Inhibition of electric eel AChE-mediated amyloid beta (1 to 40) fibril formation at 10 uM after 24 hrs by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID697833Inhibition of human AChE by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID282830Inhibition of human AChE-induced beta amyloid peptide(1-40) aggregation by thioflavin T-based fluorometric assay2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
AID1784489Inhibition of human recombinant BACE-1 expressed in Escherichia coli using panvera peptide as a substrate incubated for 1 hr by fluorescence analysis2021European journal of medicinal chemistry, Dec-05, Volume: 225From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
AID404437Inhibition of mouse AChE2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
AID427194Inhibition of human recombinant BACE1 at 2.5 uM by fluorimetric assay2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
AID314112Inhibition of human AchE-induced amyloid beta aggregation2008Journal of medicinal chemistry, Feb-14, Volume: 51, Issue:3
Multi-target-directed ligands to combat neurodegenerative diseases.
AID1250191Induction of DNA intercalation in Escherichia coli pBR322 plasmid DNA assessed as supercoiled DNA formation at 10 ug/ml after 1 hr by agarose gel electrophoresis2015European journal of medicinal chemistry, Sep-18, Volume: 102Design and synthesis of 2-phenylnaphthalenoids and 2-phenylbenzofuranoids as DNA topoisomerase inhibitors and antitumor agents.
AID238797Competitive inhibition constant for Acetylcholinesterase2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
AID648658Inhibition of Electrophorus electricus AChE using acetylthiocholine chloride as substrate after 15 mins incubation by Ellman's method2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID595289Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID1784498Inhibition of amyloid beta (1 to 42) (unknown origin) aggregation in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control2021European journal of medicinal chemistry, Dec-05, Volume: 225From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
AID421518Inhibition of human recombinant AChE-mediated amyloid beta aggregation at 100 uM2009European journal of medicinal chemistry, Jun, Volume: 44, Issue:6
Synthesis, biological evaluation and molecular modeling of oxoisoaporphine and oxoaporphine derivatives as new dual inhibitors of acetylcholinesterase/butyrylcholinesterase.
AID670566Inhibition of BACE12012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.
AID345208Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T formation assay2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
AID1071357Inhibition of human recombinant AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition by Ellman's method2014European journal of medicinal chemistry, Feb-12, Volume: 731,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
AID345207Inhibition of human recombinant AChE-induced amyloid beta (1-40) aggregation at 100 uM by thioflavin T formation assay2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
AID427189Inhibition of human serum BChE by Ellman's method2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
AID298279Inhibition of human recombinant butyrylcholinesterase2007Journal of medicinal chemistry, Oct-04, Volume: 50, Issue:20
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
AID298281Inhibition of self-induced amyloid beta (1-40) aggregation at 10 uM by thioflavin T based fluorometric assay2007Journal of medicinal chemistry, Oct-04, Volume: 50, Issue:20
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
AID499449Binding affinity to Electrophorus electricus AChE peripheral anionic site2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyri
AID482894Inhibition of AChE2010European journal of medicinal chemistry, Mar, Volume: 45, Issue:3
Prediction of acetylcholinesterase inhibitors and characterization of correlative molecular descriptors by machine learning methods.
AID345206Inhibition of human serum BChE by Ellman's assay2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
AID595291Selectivity ratio of IC50 for human BChE to IC50 for human AChE2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID697851Inhibition of electric eel AChE-mediated amyloid beta (1 to 40) fibril formation at 100 uM after 24 hrs by thioflavin T fluorescence method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID345205Inhibition of human recombinant AChE by Ellman's assay2008Journal of medicinal chemistry, Nov-27, Volume: 51, Issue:22
Structure-activity relationships of acetylcholinesterase noncovalent inhibitors based on a polyamine backbone. 4. Further investigation on the inner spacer.
AID318849Inhibition of human recombinant AChE-induced amyloid beta aggregation at 100 uM by thioflavin T fluorescence method2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
AID621452Inhibition of amyloid beta (1 to 40) self-aggregation at 100 uM after 24 hrs by thioflavin T-based fluorometric assay2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation.
AID427192Inhibition of human recombinant AChE-induced amyloid beta (1-40) aggregation at 100 uM by thioflavin T fluorescence method2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
AID54458Binding affinity for DNA at pH 71991Journal of medicinal chemistry, Feb, Volume: 34, Issue:2
Quantitative structure-activity relationship analysis of cation-substituted polyaromatic compounds as potentiators (amplifiers) of bleomycin-mediated degradation of DNA.
AID427188Inhibition of AChE in human erythrocytes by Ellman's method2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
AID654177Inhibition of bovine AChE-induced coumarin-tagged PrP106-126 aggregation at 100 uM after 48 hrs by fluorescence microscopy2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
AID744315Inhibition of amyloid beta(1 to 42) (unknown origin) self-aggregation at 25 uM after 48 hrs by ThT fluorescence assay relative to control2013European journal of medicinal chemistry, May, Volume: 63Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID1784499Inhibition of tau aggregation (unknown origin) in Escherichia coli BL21 (DE3) at 10 uM incubated overnight by thioflavin S based fluorescence analysis relative to control2021European journal of medicinal chemistry, Dec-05, Volume: 225From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
AID462839Inhibition of Electrophorus electricus AChE-induced amyloid beta (1-40) aggregation at 25 uM by thioflavin T fluorescence assay2010Bioorganic & medicinal chemistry, Mar-15, Volume: 18, Issue:6
Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus.
AID282831Inhibition of beta amyloid protein 40 aggregation at 100 uM by thioflavin T-based fluorometric assay2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Design, synthesis, and biological evaluation of dual binding site acetylcholinesterase inhibitors: new disease-modifying agents for Alzheimer's disease.
AID694784Inhibition of amyloid beta (1 to 42) self-aggregation at 20 uM after 24 hrs by thioflavin T fluorescence assay2012Bioorganic & medicinal chemistry, Nov-01, Volume: 20, Issue:21
Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca²⁺ overload.
AID744300Cytotoxicity against human SH-SY5Y cells assessed as cell viability after 48 hrs by MTT assay2013European journal of medicinal chemistry, May, Volume: 63Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID670568Inhibition of human AChE-induced amyloid beta (1 to 40) aggregation at 100 uM after 24 hrs by thioflavin T-based fluorescence analysis2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.
AID314091Inhibition of human AchE2008Journal of medicinal chemistry, Feb-14, Volume: 51, Issue:3
Multi-target-directed ligands to combat neurodegenerative diseases.
AID404439Inhibition of bovine AChE2008Journal of medicinal chemistry, Jun-12, Volume: 51, Issue:11
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
AID635889Inhibition of self-induced amyloid beta (1 to 42) aggregation at 1:1 amyloid beta to compound concentration measured every 10 mins for 10 hrs by thioflavin T-based fluorometric analysis2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's di
AID298278Inhibition of human recombinant acetylcholinesterase2007Journal of medicinal chemistry, Oct-04, Volume: 50, Issue:20
Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.
AID1071355Inhibition of human serum BChE using butyrylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method2014European journal of medicinal chemistry, Feb-12, Volume: 731,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
AID366355Inhibition of Electrophorus electricus AChE by Ellman's method2008Bioorganic & medicinal chemistry, Aug-15, Volume: 16, Issue:16
New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties.
AID1054123Inhibition of wild type mouse AChE expressed in HEK293 cells using ATCh as substrate2013Journal of medicinal chemistry, Oct-10, Volume: 56, Issue:19
Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.
AID1784491Inhibition of human recombinant AChE using acetylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis2021European journal of medicinal chemistry, Dec-05, Volume: 225From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
AID744313Non-competitive inhibition of acetylcholinesterase (unknown origin)-induced amyloid beta(1 to 42) aggregation at 25 uM after 6 hrs by ThT fluorescence assay relative to control2013European journal of medicinal chemistry, May, Volume: 63Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID635887Inhibition of self-induced amyloid beta (1 to 42) aggregation at 10 uM measured every 10 mins for 10 hrs by thioflavin T-based fluorometric analysis2011Journal of medicinal chemistry, Dec-22, Volume: 54, Issue:24
Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's di
AID1071359Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 20 mins followed by substrate addition measured after 5 mins by Ellman's method2014European journal of medicinal chemistry, Feb-12, Volume: 731,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
AID241279Inhibition of Acetylcholinesterase2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
AID623720Inhibition of human recombinant AChE-mediated amyloid beta (1-40) aggregation at 100 uM after 48 hrs by thioflavin T fluorescence assay2011Journal of natural products, Oct-28, Volume: 74, Issue:10
Benzofurans from Styrax agrestis as acetylcholinesterase inhibitors: structure-activity relationships and molecular modeling studies.
AID654191Inhibition of AChE-induced of PrP82-146 aggregation at 100 uM2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
AID621451Inhibition of human AChE-induced amyloid beta (1-40) aggregation at 100 uM after 24 hrs by thioflavin T-based fluorometric assay2011Bioorganic & medicinal chemistry letters, Oct-01, Volume: 21, Issue:19
Development of 2-substituted-N-(naphth-1-ylmethyl) and N-benzhydrylpyrimidin-4-amines as dual cholinesterase and Aβ-aggregation inhibitors: Synthesis and biological evaluation.
AID1784492Inhibition of human serum BChE using butyrylthiocholine iodide as a substrate preincubated for 20 mins followed by substrate addition by spectrophotometric analysis2021European journal of medicinal chemistry, Dec-05, Volume: 225From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects.
AID695925Inhibition of HIV-1 reverse transcriptase using Poly(rA).p(dT) (12 to 18) as substrate after 30 mins by single point PCR assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Inhibition of therapeutically important polymerases with high affinity bis-intercalators.
AID670569Inhibition of self-induced amyloid beta (1 to 40) aggregation at 100 uM after 24 hrs by thioflavin T-based fluorescence analysis2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Development and evaluation of multifunctional agents for potential treatment of Alzheimer's disease: application to a pyrimidine-2,4-diamine template.
AID744309Antioxidant activity of the compound assessed as trolox equivalent of APPH-induced radical scavenging activity at 1 uM incubated for 15 mins measured every 1 min for 240 mins by ORAC-FL assay2013European journal of medicinal chemistry, May, Volume: 63Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
AID595290Inhibition of human BChE using butyrylthiocholine iodide as substrate by Ellman's method2011European journal of medicinal chemistry, May, Volume: 46, Issue:5
Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID427190Selectivity ratio of IC50 for human serum BChE to IC50 for AChE in human erythrocytes2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
AID648661Inhibition of Electrophorus electricus AChE-induced beta-amyloid (1 to 40) aggregation at 100 uM after 8 hrs by thioflavin-T based fluorescence assay2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID427193Inhibition of self-induced amyloid beta (1-42) aggregation at 50 uM by thioflavin T fluorescence method2009Journal of medicinal chemistry, Sep-10, Volume: 52, Issue:17
Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.
AID654176Inhibition of human recombinant AChE-induced Abeta1-40 aggregation at 100 uM by thioflavin T fluorescence method2012Journal of medicinal chemistry, Jan-26, Volume: 55, Issue:2
Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.
AID1445549Inhibition of human recombinant AChE-induced human amyloid beta (1 to 40 residues) aggregation at 100 uM after 24 hrs by thioflavine T fluorescence method2017Journal of medicinal chemistry, 07-13, Volume: 60, Issue:13
Donepezil-Based Central Acetylcholinesterase Inhibitors by Means of a "Bio-Oxidizable" Prodrug Strategy: Design, Synthesis, and in Vitro Biological Evaluation.
AID771013Induction of DNA intercalation activity of calf thymus DNA topoisomerase 1 assessed as unwinding of pBR322 DNA at 10 ug/ml after 30 mins by Agarose gel electrophoresis2013European journal of medicinal chemistry, Oct, Volume: 68A novel p-terphenyl derivative inducing cell-cycle arrest and apoptosis in MDA-MB-435 cells through topoisomerase inhibition.
AID31795Dissociation constant towards Acetylcholinesterase in mouse2004Journal of medicinal chemistry, Jul-01, Volume: 47, Issue:14
Fragment-based drug discovery.
AID318850Inhibition of human recombinant AChE-induced amyloid beta aggregation at 200 uM by thioflavin T fluorescence method2008Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
AID648664Non-competitive inhibition of human recombinant AChE-induced beta-amyloid (1 to 40) aggregation at 100 uM by thioflavin-T based fluorimetric assay2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID247996Inhibitory concentration against amyloid-beta aggregation2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Propidium-based polyamine ligands as potent inhibitors of acetylcholinesterase and acetylcholinesterase-induced amyloid-beta aggregation.
AID648662Inhibition of Electrophorus electricus AChE-induced beta-amyloid (1 to 40) aggregation at 10 uM after 8 hrs by thioflavin-T based fluorescence assay2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Novel oxoisoaporphine-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (37)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.70)18.2507
2000's11 (29.73)29.6817
2010's24 (64.86)24.3611
2020's1 (2.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 79.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index79.72 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index5.75 (4.65)
Search Engine Demand Index133.76 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (79.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (8.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (91.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]